Early Detection and Diagnosis of Mild Cognitive Impairment and Alzheimers Disease

In the context of a patient case presentation, expert faculty will highlight the stages of Alzheimer disease (AD) and the vital importance of early detection of mild cognitive impairment (MCI). They will discuss screening for MCI and current guidelines and standards of care for establishing a diagnosis of AD. The faculty will also examine the effects of increasingly more accessible neuroimaging and fluid markers on the diagnosis of AD, especially with the recent FDA approvals of anti-amyloid therapies.

Learning Objectives

  • Incorporate strategies that promote the early detection of mild cognitive impairment (MCI) due to Alzheimer disease (AD) into routine primary care practice
  • Discuss the clinical evaluation involved in diagnosing AD, with consideration of the expanding role of biomarkers

Additional Information

Course summary
Available credit: 
  • 0.58 AANP Contact Hours
  • 0.50 AMA PRA Category 1 Credit
Course opens: 
Course expires: 

Available Credit

  • 0.58 AANP Contact Hours
  • 0.50 AMA PRA Category 1 Credit
Please login or register to take this course.

This course is offered through Pri-Med. 


To take this course you will be redirected to Pri-Med's website. You must login or create an account with Pri-Med in order to complete this activity. 


Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!